Dear International Growth Fund Shareholder: Baron International Growth Fund® (BINIX, the Fund) gained 8.07% (Institutional Shares) during the third quarter of 2024, while its...
This article was written by Follow Striving to uncover long-term investment opportunities (10+ years) through in-depth research and analysis. Nexus Research seeks to evaluate...
This article was written by Follow Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment...
Investment thesis Our current investment thesis is: JHG has struggled with growth, as investors are increasingly unconvinced by the value offered by active management....
Introduction ImmunoGen (NASDAQ:IMGN) is a commercial-stage biotech firm focused on developing innovative antibody-drug conjugates (ADCs) to enhance cancer treatment. These targeted therapies boast improved...
Intro Churchill Downs Incorporated (NASDAQ:CHDN) is a prominent entertainment company in the United States that operates in the racing, online wagering, and gaming sectors....
The Food and Drug Administration (FDA) has granted final approval to the anti-Alzheimer’s drug lecanamab, marked as Leqembi by drugmakers Eisai and Biogen BIIB...